ECONOMIC EVALUATION AND THE POSTPONEMENT OF HEALTH CARE COSTS
The inclusion of medical costs in life years gained in economic evaluations of health care technologies has long been controversial. Arguments in favour of the inclusion of such costs are gaining support, which shifts the question from whether to how to include these costs. This paper elaborates on the issue how to include cost in life years gained in cost effectiveness analysis given the current practice of economic evaluations in which costs of related diseases are included. We combine insights from the theoretical literature on the inclusion of unrelated medical costs in life years gained w... Mehr ...
Verfasser: | |
---|---|
Dokumenttyp: | Artikel |
Erscheinungsdatum: | 2011 |
Reihe/Periodikum: | van Baal , P H M , Feenstra , T L , Polder , J J , Hoogenveen , R T & Brouwer , W B F 2011 , ' ECONOMIC EVALUATION AND THE POSTPONEMENT OF HEALTH CARE COSTS ' , Health Economics , vol. 20 , no. 4 , pp. 432-445 . https://doi.org/10.1002/hec.1599 |
Schlagwörter: | economic evaluation / medical costs in life years gained / modeling / cost effectiveness analysis / FUTURE COSTS / MEDICAL COSTS / LAST YEAR / LIFE / EXPENDITURE / SMOKING / INTERVENTIONS / PREVENTION / IMPACT / NETHERLANDS |
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-27602005 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | https://hdl.handle.net/11370/c6733bdd-74ac-493f-a64f-b1a90b9335f0 |